Food As Medicine for Maternal Health and High-Risk Pregnancy: Examining the Immediate and Long-term Impacts of Maternal Nutrition as an Intervention – Yahoo Finance

HOUSTON, October 20, 2022–(BUSINESS WIRE)–How can a country that leads the world in medical innovation and healthcare spending per capita have a maternal health crisis? Maternal mortality in the U.S. far outstrips that of other industrialized nations, at 23.8 deaths per 100,000 live births. We have 2.2 million American women living in maternity care deserts. The rate of gestational diabetes has increased 30% in young U.S. women over the past decade. Even more concerning, worsening, mostly preventable maternal health risks have an outsized effect on BIPOC, rural and low-income women.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221020005149/en/
Suboptimal nutritional during pregnancy is associated with a higher risk of negative maternal and fetal outcomes. Umoja Food For Health 2022 (Graphic: Business Wire)
Pregnancy healthcare providers have long recognized the importance of nutrition before, during, and after pregnancy. Suboptimal diets are a leading risk factor for chronic diseases such as obesity, hypertension, and diabetes, that significantly impact maternal health. Food-as-medicine interventions provide access to optimal nutrition, reduce risk factors and improve outcomes, help to lower the overall cost of care, and must become a formal, consistent component of pregnancy and postpartum care.
“The outsized impact our maternal health crisis is having on our black mothers, rural mothers, low-income mothers, and their communities is alarming. Effectively addressing social determinants of health and maternal health inequities requires collaboration with government, nongovernment and private sector partners,” said Dr. James Gillespie, Chief Health Officer at Umoja Food For Health and a member of the Milken Institute’s Food Is Medicine Task Force. In their white paper Food For Health: the positive economic, medical, and social impact of maternal nutrition as an intervention, Dr. Gillespie and co-author Dr. Gregory Privitera of St. Bonaventure University explore key findings indicating the significant influence food and nutrition access have on aspects of maternal population health, optimal fetal development, improved perinatal survival, and overall short- and long-term health of the baby.
Nutrition security during pregnancy is critical. Consistent, equitable access to healthy, safe, affordable foods is essential to optimal health and wellbeing. “Preexisting chronic diabetes and obesity, and the development of gestational diabetes increase risks of serious complications during pregnancy and delivery. These conditions can be managed, and in some cases prevented through diet, exercise, and stress management. Food as medicine interventions play a key role by providing for optimal nutrition and addressing food and nutrition insecurity stressors,” says Gillespie.
To prioritize women’s health before, during and after pregnancy; to reduce maternal risk factors and mortality rates; and to ensure health equity, reduce spending and build healthier communities we must look at maternal health through a broader lens. We must address barriers to optimal nutrition and food access. We must adopt more food-as-medicine initiatives across public and private spheres, and at local, state, and federal levels for pregnant women, future mothers, and the health of the next generation.
About Umoja Food For Health
Food For Health offers medically tailored meal, grocery and produce programs delivering nutritious foods and educational tools to improve health, address social determinants of health, and support the prevention or management of chronic conditions. Food For Health is a division of Umoja Supply Chain Solutions. Umoja leverages decades of expertise in food and logistics to tackle big problems with big solutions through four core divisions – Food For Health, Hunger Relief, Third-party Logistics, and Government. Umoja is mission-driven, with a focus on ensuring equity and access to quality food and healthcare for all. www.umojasupply.com/food-for-health. https://www.linkedin.com/company/umoja-supply/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221020005149/en/
Contacts
Melissa Hunter
Food For Health, Umoja Supply Chain Solutions
(832) 968-6117
Mhunter@umojasupply.com
www.umojasupply.com
We’re in a volatile bear market right now, and key riddle investors need to answer is, which stocks are going to bring the best returns, even in today’s uncertain conditions. One market segment that can’t be ignored is the low-cost penny stocks. These equities, typically priced under $5 per share, offer the best combination of risk and reward: a minimal cost of entry, and frequently triple-digit upside potential. Going beyond the argument that you get more for your money, even minor price apprec
Despite CRISPR stocks' enthusiasm, the risk of potential cures continues to cloud market projections for new gene-editing treatments.
Alzheimer's therapies are big news lately. The disease is the leading cause of dementia and memory loss. The Alzheimer's Association estimates that 6.5 million Americans 65 and older are living with Alzheimer's dementia (AD) and by 2050, the number of people 65 and older with AD is projected to reach 12.7 million.
Early this month, the World Health Organization’s director said that ingredients in four cold and cough syrups made in India may have been linked to acute kidney injuries and the deaths of 66 children in Gambia — and that the products may have been distributed to other countries. Days later, authorities in India began an investigation and halted all production by the company that made the tainted medication. This week, authorities in Indonesia banned the sale of all cough syrups nationwide. They
Shares of Biogen (NASDAQ: BIIB) have been volatile in the past few years, largely hinging on success of the company's Alzheimer's treatments. Sales in recent years have been declining, and the loss of patent protection for top-selling multiple sclerosis treatment Tecfidera is only exacerbating those concerns. What will the company's business look like over the next five years, and is it promising enough for investors to buy shares of Biogen today?
Picking the right markets to compete in makes surviving bear markets much more manageable for these companies.
Biotech company Novavax (NASDAQ: NVAX) has had a terrible year on the stock market, with its shares down by 86% year to date. The company does still face some challenges. The coronavirus vaccine market, where it plans to make its money for the next few years, could shrink substantially starting next year.
Regulatory and pipeline updates from NERV and RLMD are the key highlights from the biotech sector during the past week.
Talaris Therapeutics (TALS) reports a patient death from its late-stage study evaluating its experimental drug, FCR001, in living donor kidney transplant patients. Stock down.
The WHO found that omicron subvariant XBB, which may be even more resistant to antibodies than other variants, spread to more countries in the week ending Oct. 16 from the previous week.
You’ve basically lived at the farmer’s market this summer, but now there’s a chill in the air and you’re lamenting the end of veggie season. Don’t worry, you needn’t dine exclusively on mac and cheese and chicken pot pie from December through February—there's a whole host of delicious winter vegetables that promise to please your taste buds while doing good things for your waistline and your overall health. 13 Vegetables That Last the Longest (If You Know How to Store Them) What are winter veget
AbbVie (NYSE: ABBV) today announced Health Canada approval for SKYRIZI® (risankizumab 600 mg intravenous [IV] induction at Week 0, Week 4 and Week 8, followed by 360 mg subcutaneous [SC] injection maintenance at Week 12 and every eight weeks thereafter) for the treatment of adults with moderately to severely active Crohn's disease who have had an inadequate response, intolerance, or demonstrated dependence to corticosteroids; or an inadequate response, intolerance, or loss of response to immunom
The British actress talks about her mission to empower women and challenge taboos.
As a wave of COVID from the latest subvariants is expected this winter, costs of vaccines could rise as the federal government runs out of money.
The U.S. is seeing an alarming surge in respiratory viruses like RSV among kids. One hospital is so slammed its considering asking the national guard for help.
Some epidemiologists are predicting a rise in cases of COVID starting soon with Halloween & winter setting in. We share latest on why and what to do.
Four people linked to viral video footage of Mississippi day care employees using a scary mask to frighten young children are facing charges of felony child abuse, and a fifth person faces two misdemeanor counts, authorities say. The daycare’s owner, Sheila Sanders, is not facing charges.
Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced an extension of its Ace Valley brand portfolio with the launch of Lust Cherry Rose and Thrust Watermelon Goji. These two new, distinctly-flavoured, gummies are the first of their kind in the Canadian market, celebrating the intersection of cannabis and sex positivity by empowering consumers to enhance their pe
RedHill Biopharma (RDHL) receives a new patent from the United States Patent and Trademark Office for its investigational COVID-19 candidate, opaganib, in COVID-19 patients with pneumonia. Stock up.
Photo Illustration by The Daily Beast / GettyWe’re all going to die eventually—but what if you knew when you’d be at risk for dropping dead, based solely on the way you walk? A new study shows that measurements taken with wrist-worn motion sensors can be used to predict one’s mortality risk up to five years later. As one of the largest validations of wearable technology to date, the research raises the possibility of one day using the motion detection system in smartphones to survey patient heal

source